Blood products company Haemonetics (NYSE:HAE). will be reporting earnings this Thursday before market open. Here’s what to expect. Haemonetics beat analysts’ revenue expectations by 5.3% last quarter, ...

SAN ANTONIO -- Among patients with hereditary angioedema (HAE), monthly injections of the investigational biologic garadacimab reduced the mean attack rate substantially in the phase III VANGUARD ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that the European Commission (EC) has approved DAWNZERA™ (donidalorsen) in the European Union ...

Riverwater Partners, an investment management company, released its “Sustainable Value Strategy” Q4 2025 investor letter. A ...

These incredible moments show why Cha Hae-In could compete for the best main character in Solo Leveling Season 3.

Jin-Woo defeated the Ant King in the Jeju Island Arc but struggles to heal Cha Hae-In. Hae-In's condition worsens despite Jin-Woo's efforts, leading to a desperate search for a solution. Shadow ...

Initial findings from a Phase 3 efficacy trial suggest Ionis Pharmaceuticals’ RNA-targeted treatment, given monthly or bimonthly, cut angioedema attacks more than placebo, the firm said Monday. The ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

Haemonetics (HAE) has been beaten down lately with too much selling pressure. While the stock has lost 5.2% over the past four weeks, there is light at the end of the tunnel as it is now in oversold ...

Cathlyn Melo is an experienced anime writer from the Philippines with a Master in Business Administration. She was once a hospital employee before deciding to pursue her passion for anime and manga ...